164 related articles for article (PubMed ID: 9160304)
1. Immunophenotypic analysis of ovarian and testicular Müllerian papillary serous tumors.
Carano KS; Soslow RA
Mod Pathol; 1997 May; 10(5):414-20. PubMed ID: 9160304
[TBL] [Abstract][Full Text] [Related]
2. Paratesticular müllerian-type papillary serous tumor in a child.
Cohen MC; Shawis R; Evans C
Pediatr Dev Pathol; 2009; 12(4):297-300. PubMed ID: 19348511
[TBL] [Abstract][Full Text] [Related]
3. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
Karaferic A; Jovanovic D; Jelic S
J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
[TBL] [Abstract][Full Text] [Related]
4. Serous borderline tumor of the paratestis.
Maruyama H; Ohyama N; Hosokawa Y; Momose H; Yamada K; Tsutsumi M; Kuniyasu H; Enomoto Y; Uematsu K; Konishi Y
Pathol Int; 2008 May; 58(5):311-6. PubMed ID: 18429831
[TBL] [Abstract][Full Text] [Related]
5. Papillary serous carcinoma of ovarian type of the testis with borderline differentiation.
Guarch R; Rivas A; Puras A; Pesce C
Histopathology; 2005 May; 46(5):588-90. PubMed ID: 15842644
[No Abstract] [Full Text] [Related]
6. A case of intratesticular endometrioid papillary cystadenocarcinoma.
Numakura K; Tsuchiya N; Tsuruta H; Obara T; Saito M; Inoue T; Narita S; Horikawa Y; Satoh S; Nanjyo H; Habuchi T
Jpn J Clin Oncol; 2011 May; 41(5):674-6. PubMed ID: 21474549
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
[TBL] [Abstract][Full Text] [Related]
8. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
9. Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.
Ohishi Y; Oda Y; Kurihara S; Kaku T; Yasunaga M; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Aug; 40(8):1168-75. PubMed ID: 19368953
[TBL] [Abstract][Full Text] [Related]
10. Borderline serous papillary tumour of the testis: a case report and review of the literature.
Ibrahim AS; Li C; Al-Jafari MS
Anticancer Res; 2012 Nov; 32(11):5011-3. PubMed ID: 23155272
[TBL] [Abstract][Full Text] [Related]
11. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
12. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
13. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
17. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
Ordóñez NG
Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
[TBL] [Abstract][Full Text] [Related]
18. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
[TBL] [Abstract][Full Text] [Related]
19. Serous borderline tumor of the paratestis: a report of seven cases.
McClure RF; Keeney GL; Sebo TJ; Cheville JC
Am J Surg Pathol; 2001 Mar; 25(3):373-8. PubMed ID: 11224608
[TBL] [Abstract][Full Text] [Related]
20. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
Soslow RA; Ali A; Oliva E
Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
